| Year |
Citation |
Score |
| 2024 |
Rios S, Bhattachan B, Vavilikolanu K, Kitsou C, Pal U, Schnell MJ. The Development of a Rabies Virus-Vectored Vaccine against , Targeting BBI39. Vaccines. 12. PMID 38250891 DOI: 10.3390/vaccines12010078 |
0.403 |
|
| 2023 |
Scher G, Bente DA, Mears MC, Cajimat MNB, Schnell MJ. GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus. Npj Vaccines. 8: 73. PMID 37210392 DOI: 10.1038/s41541-023-00663-5 |
0.401 |
|
| 2023 |
Yankowski C, Kurup D, Wirblich C, Schnell MJ. Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. Npj Vaccines. 8: 10. PMID 36754965 DOI: 10.1038/s41541-023-00615-z |
0.476 |
|
| 2022 |
Yankowski C, Wirblich C, Kurup D, Schnell MJ. Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity. Npj Vaccines. 7: 110. PMID 36151100 DOI: 10.1038/s41541-022-00532-7 |
0.423 |
|
| 2022 |
Kurup D, Wirblich C, Zabihi Diba L, Lambert R, Watson M, Shaikh N, Ramage H, Solomides C, Schnell MJ. A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model. Viruses. 14. PMID 35746597 DOI: 10.3390/v14061126 |
0.437 |
|
| 2022 |
Kurup D, Myers J, Schnell MJ. Current vaccine strategies against SARS-CoV-2: Promises and challenges. The Journal of Allergy and Clinical Immunology. PMID 35618046 DOI: 10.1016/j.jaci.2022.05.008 |
0.328 |
|
| 2022 |
Kurup D, Wirblich C, Lambert R, Diba LZ, Leiby BE, Schnell MJ. Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract. Npj Vaccines. 7: 43. PMID 35440656 DOI: 10.1038/s41541-022-00464-2 |
0.376 |
|
| 2021 |
Malherbe DC, Kurup D, Wirblich C, Ronk AJ, Mire C, Kuzmina N, Shaik N, Periasamy S, Hyde MA, Williams JM, Shi PY, Schnell MJ, Bukreyev A. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19. Npj Vaccines. 6: 91. PMID 34294728 DOI: 10.1038/s41541-021-00352-1 |
0.425 |
|
| 2021 |
Kurup D, Schnell MJ. SARS-CoV-2 vaccines - the biggest medical research project of the 21st century. Current Opinion in Virology. 49: 52-57. PMID 34049261 DOI: 10.1016/j.coviro.2021.04.008 |
0.303 |
|
| 2021 |
Kurup D, Malherbe DC, Wirblich C, Lambert R, Ronk AJ, Zabihi Diba L, Bukreyev A, Schnell MJ. Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. Plos Pathogens. 17: e1009383. PMID 33765062 DOI: 10.1371/journal.ppat.1009383 |
0.383 |
|
| 2021 |
Kurup D, Fisher CR, Scher G, Yankowski C, Testa A, Keshwara R, Abreu-Mota T, Lambert R, Ferguson M, Rinaldi W, Ruiz L, Wirblich C, Schnell MJ. Tetravalent rabies-vectored Filovirus and Lassa fever vaccine induces long-term immunity in nonhuman primates. The Journal of Infectious Diseases. PMID 33421072 DOI: 10.1093/infdis/jiab014 |
0.46 |
|
| 2020 |
Scher G, Schnell MJ. Rhabdoviruses as vectors for vaccines and therapeutics. Current Opinion in Virology. 44: 169-182. PMID 33130500 DOI: 10.1016/j.coviro.2020.09.003 |
0.422 |
|
| 2020 |
Kurup D, Wirblich C, Ramage H, Schnell MJ. Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2. Npj Vaccines. 5: 98. PMID 33088593 DOI: 10.1038/s41541-020-00248-6 |
0.435 |
|
| 2020 |
Fisher CR, Lowe DE, Smith TG, Yang Y, Hutson CL, Wirblich C, Cingolani G, Schnell MJ. Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups. Cell Reports. 32: 107920. PMID 32697993 DOI: 10.1016/J.Celrep.2020.107920 |
0.517 |
|
| 2020 |
Du Pont V, Wirblich C, Yoon JJ, Cox RM, Schnell MJ, Plemper RK. Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor. Journal of Virology. PMID 32321812 DOI: 10.1128/Jvi.00321-20 |
0.406 |
|
| 2019 |
Kurup D, Fisher CR, Smith TG, Abreu-Mota T, Yang Y, Jackson FR, Gallardo-Romero N, Franka R, Bronshtein V, Schnell MJ. Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge. The Journal of Infectious Diseases. PMID 31374568 DOI: 10.1093/Infdis/Jiz332 |
0.499 |
|
| 2019 |
Keshwara R, Shiels T, Postnikova E, Kurup D, Wirblich C, Johnson RF, Schnell MJ. Erratum: Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus. Npj Vaccines. 4: 18. PMID 31098303 DOI: 10.1038/s41541-019-0112-x |
0.404 |
|
| 2019 |
Keshwara R, Shiels T, Postnikova E, Kurup D, Wirblich C, Johnson RF, Schnell MJ. Rabies-based vaccine induces potent immune responses against Nipah virus. Npj Vaccines. 4: 15. PMID 31016033 DOI: 10.1038/s41541-019-0109-5 |
0.452 |
|
| 2019 |
Taylor E, Banyard AC, Bourhy H, Cliquet F, Ertl H, Fehlner-Gardiner C, Horton DL, Mani RS, Müller T, Rupprecht CE, Schnell MJ, Del Rio Vilas V, Fooks AR. Avoiding preventable deaths: The scourge of counterfeit rabies vaccines. Vaccine. PMID 30922698 DOI: 10.1016/J.Vaccine.2019.03.037 |
0.388 |
|
| 2019 |
Qin S, Volokhov D, Rodionova E, Wirblich C, Schnell MJ, Chizhikov V, Dabrazhynetskaya A. A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies. Biologicals : Journal of the International Association of Biological Standardization. PMID 30898479 DOI: 10.1016/J.Biologicals.2019.03.002 |
0.475 |
|
| 2019 |
Du Pont V, Plemper RK, Schnell MJ. Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses. Current Opinion in Virology. 35: 1-13. PMID 30753961 DOI: 10.1016/J.Coviro.2018.12.009 |
0.408 |
|
| 2018 |
Fisher CR, Schnell MJ. New developments in rabies vaccination. Revue Scientifique Et Technique (International Office of Epizootics). 37: 657-672. PMID 30747119 DOI: 10.20506/Rst.37.2.2831 |
0.451 |
|
| 2018 |
Keshwara R, Hagen KR, Abreu-Mota T, Papaneri AB, Liu D, Wirblich C, Johnson RF, Schnell MJ. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein is Dependent Upon ADCC for Protection Against Marburg Virus Disease in a Murine Model. Journal of Virology. PMID 30567978 DOI: 10.1128/Jvi.01865-18 |
0.575 |
|
| 2018 |
Liu DX, Perry DL, Evans DeWald L, Cai Y, Hagen KR, Cooper TK, Huzella LM, Hart R, Bonilla A, Bernbaum JG, Janosko KB, Adams R, Johnson RF, Kuhn JH, Schnell MJ, et al. Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus). The Journal of Infectious Diseases. PMID 30517671 DOI: 10.1093/Infdis/Jiy641 |
0.377 |
|
| 2018 |
Abreu-Mota T, Hagen KR, Cooper K, Jahrling PB, Tan G, Wirblich C, Johnson RF, Schnell MJ. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nature Communications. 9: 4223. PMID 30310067 DOI: 10.1038/S41467-018-06741-W |
0.688 |
|
| 2018 |
Fisher CR, Streicker DG, Schnell MJ. The spread and evolution of rabies virus: conquering new frontiers. Nature Reviews. Microbiology. PMID 29479072 DOI: 10.1038/Nrmicro.2018.11 |
0.467 |
|
| 2018 |
Perry DL, Huzella LM, Bernbaum JG, Holbrook MR, Jahrling PB, Hagen KR, Schnell MJ, Johnson RF. Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease. The American Journal of Pathology. PMID 29429544 DOI: 10.1016/J.Ajpath.2017.11.004 |
0.384 |
|
| 2017 |
Davis BM, Fensterl V, Lawrence TM, Hudacek AW, Sen GC, Schnell MJ. Ifit2 is a Restriction Factor in Rabies Virus Pathogenicity. Journal of Virology. PMID 28637751 DOI: 10.1128/Jvi.00889-17 |
0.75 |
|
| 2017 |
Schnell MJ. Editorial to: 6-Month Safety Data of Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) in a Phase III Double Blind, Placebo Controlled Randomized Study in Healthy Adults. The Journal of Infectious Diseases. PMID 28431160 DOI: 10.1093/Infdis/Jix190 |
0.343 |
|
| 2017 |
Walsh PD, Kurup D, Hasselschwert DL, Wirblich C, Goetzmann JE, Schnell MJ. The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees? Scientific Reports. 7: 43339. PMID 28277549 DOI: 10.1038/Srep43339 |
0.478 |
|
| 2017 |
Budaszewski RD, Hudacek A, Sawatsky B, Krämer B, Xiangping Y, Schnell MJ, von Messling V. Inactivated Recombinant Rabies Viruses Displaying the Canine Distemper Virus Glycoproteins Induce Protective Immunity Against Both Pathogens. Journal of Virology. PMID 28148801 DOI: 10.1128/Jvi.02077-16 |
0.564 |
|
| 2016 |
Miller KD, Schnell MJ, Rall GF. Keeping it in check: chronic viral infection and antiviral immunity in the brain. Nature Reviews. Neuroscience. PMID 27811921 DOI: 10.1038/Nrn.2016.140 |
0.474 |
|
| 2016 |
Wirblich C, Coleman CM, Kurup D, Abraham TS, Bernbaum JG, Jahrling PB, Hensley LE, Johnson RF, Frieman MB, Schnell MJ. One-Health: A Safe, Efficient Dual-use Vaccine for Humans and Animals against MERS-CoV and Rabies Virus. Journal of Virology. PMID 27807241 DOI: 10.1128/Jvi.02040-16 |
0.505 |
|
| 2016 |
Keshwara R, Johnson RF, Schnell MJ. Toward an Effective Ebola Virus Vaccine. Annual Review of Medicine. PMID 27686015 DOI: 10.1146/Annurev-Med-051215-030919 |
0.525 |
|
| 2016 |
Johnson RF, Kurup D, Hagen KR, Fisher C, Keshwara R, Papaneri A, Perry DL, Cooper K, Jahrling PB, Wang JT, Ter Meulen J, Wirblich C, Schnell MJ. An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models. The Journal of Infectious Diseases. PMID 27456709 DOI: 10.1093/Infdis/Jiw231 |
0.521 |
|
| 2016 |
Reardon TR, Murray AJ, Turi GF, Wirblich C, Croce KR, Schnell MJ, Jessell TM, Losonczy A. Rabies Virus CVS-N2c(ΔG) Strain Enhances Retrograde Synaptic Transfer and Neuronal Viability. Neuron. PMID 26804990 DOI: 10.1016/J.Neuron.2016.01.004 |
0.319 |
|
| 2015 |
Davis BM, Rall GF, Schnell MJ. Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask). Annual Review of Virology. 2: 451-71. PMID 26958924 DOI: 10.1146/Annurev-Virology-100114-055157 |
0.463 |
|
| 2015 |
Willet M, Kurup D, Papaneri A, Wirblich C, Hooper JW, Kwilas SA, Keshwara R, Hudacek A, Beilfuss S, Rudolph G, Pommerening E, Vos A, Neubert A, Jahrling P, Blaney JE, ... ... Schnell MJ, et al. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses. The Journal of Infectious Diseases. PMID 26063224 DOI: 10.1093/Infdis/Jiv251 |
0.558 |
|
| 2015 |
Pfaller CK, Cattaneo R, Schnell MJ. Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics Virology. 479: 331-344. PMID 25702088 DOI: 10.1016/J.Virol.2015.01.029 |
0.438 |
|
| 2015 |
Papaneri AB, Bernbaum JG, Blaney JE, Jahrling PB, Schnell MJ, Johnson RF. Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine. Virus Research. 197: 54-8. PMID 25481284 DOI: 10.1016/J.Virusres.2014.11.028 |
0.494 |
|
| 2015 |
Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ. Rhabdovirus-based vaccine platforms against henipaviruses. Journal of Virology. 89: 144-54. PMID 25320306 DOI: 10.1128/Jvi.02308-14 |
0.514 |
|
| 2014 |
Hudacek AW, Al-Saleem FH, Willet M, Eisemann T, Mattis JA, Simpson LL, Schnell MJ. Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo. Molecular Therapy. Methods & Clinical Development. 1: 14046. PMID 26015984 DOI: 10.1038/Mtm.2014.46 |
0.454 |
|
| 2014 |
Han Z, Lu J, Liu Y, Davis B, Lee MS, Olson MA, Ruthel G, Freedman BD, Schnell MJ, Wrobel JE, Reitz AB, Harty RN. Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. Journal of Virology. 88: 7294-306. PMID 24741084 DOI: 10.1128/Jvi.00591-14 |
0.381 |
|
| 2014 |
McGettigan JP, David F, Figueiredo MD, Minke J, Mebatsion T, Schnell MJ. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs Vaccine. 32: 1716-1719. PMID 24508037 DOI: 10.1016/J.Vaccine.2014.01.043 |
0.489 |
|
| 2013 |
Papaneri AB, Wirblich C, Marissen WE, Schnell MJ. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: Implication for post-exposure treatment Vaccine. 31: 5897-5902. PMID 24120673 DOI: 10.1016/J.Vaccine.2013.09.038 |
0.368 |
|
| 2013 |
Lawrence TM, Wanjalla CN, Gomme EA, Wirblich C, Gatt A, Carnero E, García-Sastre A, Lyles DS, McGettigan JP, Schnell MJ. Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses. Plos One. 8: e67123. PMID 23840600 DOI: 10.1371/Journal.Pone.0067123 |
0.835 |
|
| 2013 |
Blaney JE, Marzi A, Willet M, Papaneri AB, Wirblich C, Feldmann F, Holbrook M, Jahrling P, Feldmann H, Schnell MJ. Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine Plos Pathogens. 9. PMID 23737747 DOI: 10.1371/Journal.Ppat.1003389 |
0.549 |
|
| 2013 |
Lawrence TM, Hudacek AW, de Zoete MR, Flavell RA, Schnell MJ. Rabies virus is recognized by the NLRP3 inflammasome and activates interleukin-1β release in murine dendritic cells. Journal of Virology. 87: 5848-57. PMID 23487464 DOI: 10.1128/JVI.00203-13 |
0.673 |
|
| 2013 |
Marston DA, McElhinney LM, Banyard AC, Horton DL, Núñez A, Koser ML, Schnell MJ, Fooks AR. Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein. The Journal of General Virology. 94: 284-92. PMID 23100360 DOI: 10.1099/Vir.0.048827-0 |
0.478 |
|
| 2013 |
Lawrence TM, Wanjalla CN, Gomme EA, Wirblich C, Gatt A, Carnero E, García-Sastre A, Lyles DS, McGettigan JP, Schnell MJ. Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses Plos One. 8. DOI: 10.1371/journal.pone.0067123 |
0.784 |
|
| 2012 |
Gomme EA, Wirblich C, Addya S, Rall GF, Schnell MJ. Immune Clearance of Attenuated Rabies Virus Results in Neuronal Survival with Altered Gene Expression Plos Pathogens. 8. PMID 23071441 DOI: 10.1371/Journal.Ppat.1002971 |
0.787 |
|
| 2012 |
Papaneri AB, Wirblich C, Cann JA, Cooper K, Jahrling PB, Schnell MJ, Blaney JE. A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence Virology. 434: 18-26. PMID 22889613 DOI: 10.1016/J.Virol.2012.07.020 |
0.53 |
|
| 2012 |
Papaneri AB, Wirblich C, Cooper K, Jahrling PB, Schnell MJ, Blaney JE. Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein Vaccine. 30: 6136-6141. PMID 22884661 DOI: 10.1016/J.Vaccine.2012.07.073 |
0.57 |
|
| 2012 |
Nguyen TD, Wirblich C, Aizenman E, Schnell MJ, Strick PL, Kandler K. Targeted single-neuron infection with rabies virus for transneuronal multisynaptic tracing. Journal of Neuroscience Methods. 209: 367-70. PMID 22749814 DOI: 10.1016/J.Jneumeth.2012.06.019 |
0.327 |
|
| 2012 |
Nunnari G, Coco C, Pinzone MR, Pavone P, Berretta M, Di Rosa M, Schnell M, Calabrese G, Cacopardo B. The role of micronutrients in the diet of HIV-1-infected individuals Frontiers in Bioscience - Elite. 4: 2442-2456. PMID 22652651 DOI: 10.2741/E556 |
0.401 |
|
| 2012 |
Wanjalla CN, Goldstein EF, Wirblich C, Schnell MJ. A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8+ T cell responses to rabies virus Virology. 426: 120-133. PMID 22341782 DOI: 10.1016/J.Virol.2012.01.025 |
0.738 |
|
| 2011 |
Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. Journal of Virology. 85: 10605-16. PMID 21849459 DOI: 10.1128/Jvi.00558-11 |
0.529 |
|
| 2011 |
Gomme EA, Wanjalla CN, Wirblich C, Schnell MJ. Rabies virus as a research tool and viral vaccine vector. Advances in Virus Research. 79: 139-64. PMID 21601047 DOI: 10.1016/B978-0-12-387040-7.00009-3 |
0.818 |
|
| 2011 |
Mustafa W, Al-Saleem FH, Nasser Z, Olson RM, Mattis JA, Simpson LL, Schnell MJ. Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge. Vaccine. 29: 4638-45. PMID 21549784 DOI: 10.1016/J.Vaccine.2011.04.045 |
0.468 |
|
| 2011 |
Wirblich C, Schnell MJ. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. Journal of Virology. 85: 697-704. PMID 21068252 DOI: 10.1128/Jvi.01309-10 |
0.429 |
|
| 2010 |
Wanjalla CN, Faul EJ, Gomme EA, Schnell MJ. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity. Vaccine. 29: 130-40. PMID 20728525 DOI: 10.1016/J.Vaccine.2010.08.042 |
0.808 |
|
| 2010 |
Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. Plos Pathogens. 6: e1001016. PMID 20661430 DOI: 10.1371/Journal.Ppat.1001016 |
0.779 |
|
| 2010 |
Langley WA, Bradley KC, Li ZN, Smith ME, Schnell MJ, Steinhauer DA. Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways. Journal of Virology. 84: 8300-7. PMID 20504926 DOI: 10.1128/Jvi.00183-10 |
0.529 |
|
| 2010 |
Préhaud C, Wolff N, Terrien E, Lafage M, Mégret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Ménager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, et al. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Science Signaling. 3: ra5. PMID 20086240 DOI: 10.1126/Scisignal.2000510 |
0.602 |
|
| 2010 |
Gomme EA, Faul EJ, Flomenberg P, McGettigan JP, Schnell MJ. Characterization of a single-cycle rabies virus-based vaccine vector. Journal of Virology. 84: 2820-31. PMID 20053743 DOI: 10.1128/Jvi.01870-09 |
0.828 |
|
| 2010 |
Schnell MJ, McGettigan JP, Wirblich C, Papaneri A. The cell biology of rabies virus: using stealth to reach the brain. Nature Reviews. Microbiology. 8: 51-61. PMID 19946287 DOI: 10.1038/Nrmicro2260 |
0.468 |
|
| 2010 |
Mareeva T, Wanjalla C, Schnell MJ, Sykulev Y. A novel composite immunotoxin that suppresses rabies virus production by the infected cells. Journal of Immunological Methods. 353: 78-86. PMID 19932697 DOI: 10.1016/J.Jim.2009.11.010 |
0.702 |
|
| 2009 |
Faul EJ, Lyles DS, Schnell MJ. Interferon response and viral evasion by members of the family rhabdoviridae. Viruses. 1: 832-51. PMID 21994572 DOI: 10.3390/V1030832 |
0.83 |
|
| 2009 |
Faul EJ, Aye PP, Papaneri AB, Pahar B, McGettigan JP, Schiro F, Chervoneva I, Montefiori DC, Lackner AA, Schnell MJ. Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge. Vaccine. 28: 299-308. PMID 19879223 DOI: 10.1016/J.Vaccine.2009.10.051 |
0.845 |
|
| 2009 |
Cenna J, Hunter M, Tan GS, Papaneri AB, Ribka EP, Schnell MJ, Marx PA, McGettigan JP. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. The Journal of Infectious Diseases. 200: 1251-60. PMID 19764884 DOI: 10.1086/605949 |
0.692 |
|
| 2009 |
Preuss MA, Faber ML, Tan GS, Bette M, Dietzschold B, Weihe E, Schnell MJ. Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers. Plos Pathogens. 5: e1000485. PMID 19543379 DOI: 10.1371/Journal.Ppat.1000485 |
0.609 |
|
| 2009 |
Snook AE, Li P, Stafford BJ, Faul EJ, Huang L, Birbe RC, Bombonati A, Schulz S, Schnell MJ, Eisenlohr LC, Waldman SA. Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Research. 69: 3537-44. PMID 19351847 DOI: 10.1158/0008-5472.Can-08-3386 |
0.784 |
|
| 2009 |
Faul EJ, Lyles DS, Schnell MJ. Interferon response and viral evasion by members of the family rhabdoviridae Viruses. 1: 832-851. DOI: 10.3390/v1030832 |
0.774 |
|
| 2008 |
Dietzschold B, Li J, Faber M, Schnell M. Concepts in the pathogenesis of rabies. Future Virology. 3: 481-490. PMID 19578477 DOI: 10.2217/17460794.3.5.481 |
0.429 |
|
| 2008 |
Faul EJ, Wanjalla CN, McGettigan JP, Schnell MJ. Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. Virology. 382: 226-38. PMID 18945463 DOI: 10.1016/J.Virol.2008.09.019 |
0.815 |
|
| 2008 |
Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine. 26: 6405-14. PMID 18804506 DOI: 10.1016/J.Vaccine.2008.08.069 |
0.718 |
|
| 2008 |
Wirblich C, Tan GS, Papaneri A, Godlewski PJ, Orenstein JM, Harty RN, Schnell MJ. PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. Journal of Virology. 82: 9730-8. PMID 18667490 DOI: 10.1128/Jvi.00889-08 |
0.675 |
|
| 2008 |
Snook AE, Stafford BJ, Li P, Tan G, Huang L, Birbe R, Schulz S, Schnell MJ, Thakur M, Rothstein JL, Eisenlohr LC, Waldman SA. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity. Journal of the National Cancer Institute. 100: 950-61. PMID 18577748 DOI: 10.1093/Jnci/Djn178 |
0.597 |
|
| 2008 |
Pulmanausahakul R, Li J, Schnell MJ, Dietzschold B. The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. Journal of Virology. 82: 2330-8. PMID 18094173 DOI: 10.1128/Jvi.02327-07 |
0.434 |
|
| 2008 |
Li J, McGettigan JP, Faber M, Schnell MJ, Dietzschold B. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway. Vaccine. 26: 419-26. PMID 18082293 DOI: 10.1016/J.Vaccine.2007.10.072 |
0.421 |
|
| 2008 |
Preuss MA, Faber M, Tan GS, Dietzschold B, Schnell MJ, Weihe E. Intravenous inoculation of silver-haired bat rabies virus, but not of a canine strain, elicits lethal encephalophathy in mice by fast brain invasion via neurosecretory hypothalamic fibers Bmc Proceedings. 2. DOI: 10.1186/1753-6561-2-s1-s35 |
0.528 |
|
| 2008 |
Prehaud C, Lafage M, Tan GS, Mégret F, Ménager P, Schnell M, Buc H, Lafon M. The cytoplasmic tail of the rabies virus G protein is an essential domain controlling death/survival in human neuronal cells Bmc Proceedings. 2. DOI: 10.1186/1753-6561-2-s1-p57 |
0.547 |
|
| 2007 |
Faber M, Faber ML, Li J, Preuss MA, Schnell MJ, Dietzschold B. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus. Journal of Virology. 81: 7041-7. PMID 17459937 DOI: 10.1128/Jvi.00357-07 |
0.462 |
|
| 2007 |
Tan GS, Preuss MA, Williams JC, Schnell MJ. The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proceedings of the National Academy of Sciences of the United States of America. 104: 7229-34. PMID 17438267 DOI: 10.1073/Pnas.0701397104 |
0.639 |
|
| 2007 |
McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease. The Journal of Infectious Diseases. 195: 980-8. PMID 17330788 DOI: 10.1086/512243 |
0.816 |
|
| 2006 |
Tang J, Murtadha M, Schnell M, Eisenlohr LC, Hooper J, Flomenberg P. Human T-cell responses to vaccinia virus envelope proteins. Journal of Virology. 80: 10010-20. PMID 17005679 DOI: 10.1128/Jvi.00601-06 |
0.447 |
|
| 2006 |
Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology. 356: 147-54. PMID 16938327 DOI: 10.1016/J.Virol.2006.07.037 |
0.58 |
|
| 2006 |
Smith ME, Koser M, Xiao S, Siler C, McGettigan JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ. Rabies virus glycoprotein as a carrier for anthrax protective antigen. Virology. 353: 344-56. PMID 16820183 DOI: 10.1016/J.Virol.2006.05.010 |
0.544 |
|
| 2006 |
Plesa G, McKenna PM, Schnell MJ, Eisenlohr LC. Immunogenicity of cytopathic and noncytopathic viral vectors. Journal of Virology. 80: 6259-66. PMID 16775313 DOI: 10.1128/Jvi.00084-06 |
0.768 |
|
| 2006 |
Tang J, Olive M, Pulmanausahakul R, Schnell M, Flomenberg N, Eisenlohr L, Flomenberg P. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology. 350: 312-22. PMID 16499941 DOI: 10.1016/J.Virol.2006.01.024 |
0.336 |
|
| 2006 |
Dave RS, McGettigan JP, Qureshi T, Schnell MJ, Nunnari G, Pomerantz RJ. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects. Virology. 348: 489-97. PMID 16480752 DOI: 10.1016/J.Virol.2006.01.013 |
0.468 |
|
| 2006 |
McGettigan JP, Koser ML, McKenna PM, Smith ME, Marvin JM, Eisenlohr LC, Dietzschold B, Schnell MJ. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2. Virology. 344: 363-77. PMID 16226782 DOI: 10.1016/J.Virol.2005.09.004 |
0.761 |
|
| 2006 |
Weihe E, Bette M, Preuss MAR, Faber M, Schäfer MK, Rehnelt J, Eiden LE, Schnell MJ, Dietzschold B. A new role for immunomodulatory neuropeptides during virus infections of the nervous system Neuropeptides. 40: 437. DOI: 10.1016/J.Npep.2006.09.032 |
0.427 |
|
| 2005 |
Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, Schnell MJ. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. Journal of Virology. 79: 14141-8. PMID 16254349 DOI: 10.1128/Jvi.79.22.14141-14148.2005 |
0.457 |
|
| 2005 |
Dietzschold B, Schnell M, Koprowski H. Pathogenesis of rabies Current Topics in Microbiology and Immunology. 292: 45-56. PMID 15981467 DOI: 10.1007/3-540-27485-5_3 |
0.421 |
|
| 2005 |
Faber M, Lamirande EW, Roberts A, Rice AB, Koprowski H, Dietzschold B, Schnell MJ. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies Journal of General Virology. 86: 1435-1440. PMID 15831955 DOI: 10.1099/Vir.0.80844-0 |
0.519 |
|
| 2005 |
Schnell MJ, Tan GS, Dietzschold B. The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines. Journal of Neurovirology. 11: 76-81. PMID 15804964 DOI: 10.1080/13550280590900436 |
0.665 |
|
| 2005 |
Tan GS, McKenna PM, Koser ML, McLinden R, Kim JH, McGettigan JP, Schnell MJ. Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach. Virology. 331: 82-93. PMID 15582655 DOI: 10.1016/J.Virol.2004.10.018 |
0.84 |
|
| 2005 |
Rajnish DS, McGettigan JP, Nunnari G, Schnell MJ, Pomerantz RJ. 999. siRNA-Mediated Interference of Double-Stranded RNA Binding Protein [E3L] Is an Effective Strategy to Inhibit Vaccinia Virus Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.546 |
0.514 |
|
| 2004 |
McKenna PM, Aye PP, Dietzschold B, Montefiori DC, Martin LN, Marx PA, Pomerantz RJ, Lackner A, Schnell MJ. Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque. Journal of Virology. 78: 13455-9. PMID 15564456 DOI: 10.1128/Jvi.78.24.13455-13459.2004 |
0.794 |
|
| 2004 |
Dietzschold ML, Faber M, Mattis JA, Pak KY, Schnell MJ, Dietzschold B. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife. Vaccine. 23: 518-24. PMID 15530701 DOI: 10.1016/J.Vaccine.2004.06.031 |
0.467 |
|
| 2004 |
Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness Proceedings of the National Academy of Sciences of the United States of America. 101: 16328-16332. PMID 15520387 DOI: 10.1073/Pnas.0407289101 |
0.441 |
|
| 2004 |
Koser ML, McGettigan JP, Tan GS, Smith ME, Koprowski H, Dietzschold B, Schnell MJ. Rabies virus nucleoprotein as a carrier for foreign antigens Proceedings of the National Academy of Sciences of the United States of America. 101: 9405-9410. PMID 15197258 DOI: 10.1073/Pnas.0403060101 |
0.697 |
|
| 2004 |
Goodrich A, Parveen Z, Dornburg R, Schnell MJ, Pomerantz RJ. Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 557-65. PMID 15093186 DOI: 10.1016/J.Ymthe.2004.01.009 |
0.37 |
|
| 2004 |
Irie T, Licata JM, McGettigan JP, Schnell MJ, Harty RN. Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. Journal of Virology. 78: 2657-65. PMID 14990685 DOI: 10.1128/Jvi.78.6.2657-2665.2004 |
0.403 |
|
| 2003 |
McKenna PM, McGettigan JP, Pomerantz RJ, Dietzschold B, Schnell MJ. Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases. Current Hiv Research. 1: 229-37. PMID 15043205 DOI: 10.2174/1570162033485320 |
0.818 |
|
| 2003 |
McKenna PM, Pomerantz RJ, Dietzschold B, McGettigan JP, Schnell MJ. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes. Journal of Virology. 77: 12782-94. PMID 14610200 DOI: 10.1128/Jvi.77.23.12782-12794.2003 |
0.762 |
|
| 2003 |
Parveen Z, Mukhtar M, Rafi M, Wenger DA, Siddiqui KM, Siler CA, Dietzschold B, Pomerantz RJ, Schnell MJ, Dornburg R. Cell-type-specific gene delivery into neuronal cells in vitro and in vivo. Virology. 314: 74-83. PMID 14517061 DOI: 10.1016/S0042-6822(03)00402-1 |
0.445 |
|
| 2003 |
McGettigan JP, Naper K, Orenstein J, Koser M, McKenna PM, Schnell MJ. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome. Journal of Virology. 77: 10889-99. PMID 14512539 DOI: 10.1128/Jvi.77.20.10889-10899.2003 |
0.767 |
|
| 2003 |
Dietzschold B, Faber M, Schnell MJ. New approaches to the prevention and eradication of rabies. Expert Review of Vaccines. 2: 399-406. PMID 12903805 DOI: 10.1586/14760584.2.3.399 |
0.47 |
|
| 2003 |
McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, Dietzschold B, Schnell MJ. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. Journal of Virology. 77: 237-44. PMID 12477829 DOI: 10.1128/Jvi.77.1.237-244.2003 |
0.805 |
|
| 2002 |
McGettigan JP, McKenna PM, Schnell MJ. HIV-1 vaccines: the search continues. Clinics in Laboratory Medicine. 22: 799-820, viii. PMID 12244598 DOI: 10.1016/S0272-2712(02)00004-5 |
0.744 |
|
| 2002 |
Dietzschold B, Schnell MJ. New approaches to the development of live attenuated rabies vaccines. Hybridoma and Hybridomics. 21: 129-34. PMID 12031103 DOI: 10.1089/153685902317401735 |
0.56 |
|
| 2002 |
Wu X, Gong X, Foley HD, Schnell MJ, Fu ZF. Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated. Journal of Virology. 76: 4153-61. PMID 11932380 DOI: 10.1128/Jvi.76.9.4153-4161.2002 |
0.426 |
|
| 2002 |
Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, Dietzschold B. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. Journal of Virology. 76: 3374-81. PMID 11884563 DOI: 10.1128/Jvi.76.7.3374-3381.2002 |
0.408 |
|
| 2002 |
Siler CA, McGettigan JP, Dietzschold B, Herrine SK, Dubuisson J, Pomerantz RJ, Schnell MJ. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Virology. 292: 24-34. PMID 11878905 DOI: 10.1006/Viro.2001.1212 |
0.463 |
|
| 2002 |
Foley HD, Otero M, Orenstein JM, Pomerantz RJ, Schnell MJ. Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells. Journal of Virology. 76: 19-31. PMID 11739668 DOI: 10.1128/Jvi.76.1.19-31.2002 |
0.515 |
|
| 2001 |
Kulkosky J, Culnan DM, Roman J, Dornadula G, Schnell M, Boyd MR, Pomerantz RJ. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood. 98: 3006-15. PMID 11698284 DOI: 10.1182/Blood.V98.10.3006 |
0.451 |
|
| 2001 |
Pulmanausahakul R, Faber M, Morimoto K, Spitsin S, Weihe E, Hooper DC, Schnell MJ, Dietzschold B. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. Journal of Virology. 75: 10800-7. PMID 11602721 DOI: 10.1128/Jvi.75.22.10800-10807.2001 |
0.504 |
|
| 2001 |
Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. Journal of Virology. 75: 10623-9. PMID 11602704 DOI: 10.1128/Jvi.75.22.10623-10629.2001 |
0.362 |
|
| 2001 |
Quiñones-Kochs MI, Schnell MJ, Buonocore L, Rose JK. Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses. Virology. 287: 427-35. PMID 11531419 DOI: 10.1006/Viro.2001.1058 |
0.374 |
|
| 2001 |
McGettigan JP, Sarma S, Orenstein JM, Pomerantz RJ, Schnell MJ. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector. Journal of Virology. 75: 8724-32. PMID 11507217 DOI: 10.1128/Jvi.75.18.8724-8732.2001 |
0.55 |
|
| 2001 |
Schnell MJ. Viral vectors as potential HIV-1 vaccines. Fems Microbiology Letters. 200: 123-9. PMID 11425463 DOI: 10.1111/J.1574-6968.2001.Tb10703.X |
0.533 |
|
| 2001 |
Morimoto K, McGettigan JP, Foley HD, Hooper DC, Dietzschold B, Schnell MJ. Genetic engineering of live rabies vaccines. Vaccine. 19: 3543-51. PMID 11348722 DOI: 10.1016/S0264-410X(01)00064-0 |
0.531 |
|
| 2001 |
Morimoto K, Schnell MJ, Pulmanausahakul R, McGettigan JP, Foley HD, Faber M, Hooper DC, Dietzschold B. High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector. Journal of Immunological Methods. 252: 199-206. PMID 11334980 DOI: 10.1016/S0022-1759(01)00353-2 |
0.515 |
|
| 2001 |
McGettigan JP, Foley HD, Belyakov IM, Berzofsky JA, Pomerantz RJ, Schnell MJ. Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates. Journal of Virology. 75: 4430-4. PMID 11287595 DOI: 10.1128/Jvi.75.9.4430-4434.2001 |
0.503 |
|
| 2001 |
Foley HD, McGettigan JP, Siler CA, Dietzschold B, Schnell MJ. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proceedings of the National Academy of Sciences of the United States of America. 97: 14680-5. PMID 11114165 DOI: 10.1073/Pnas.011510698 |
0.529 |
|
| 2001 |
Morimoto K, Foley HD, McGettigan JP, Schnell MJ, Dietzschold B. Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. Journal of Neurovirology. 6: 373-81. PMID 11031690 DOI: 10.3109/13550280009018301 |
0.478 |
|
| 2000 |
Schnell MJ, Foley HD, Siler CA, McGettigan JP, Dietzschold B, Pomerantz RJ. Recombinant rabies virus as potential live-viral vaccines for HIV-1 Proceedings of the National Academy of Sciences. 97: 3544-3549. DOI: 10.1073/Pnas.97.7.3544 |
0.471 |
|
| 1999 |
Kahn JS, Schnell MJ, Buonocore L, Rose JK. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology. 254: 81-91. PMID 9927576 DOI: 10.1006/Viro.1998.9535 |
0.444 |
|
| 1998 |
Kim SK, Reed DS, Olson S, Schnell MJ, Rose JK, Morton PA, Lefrançois L. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proceedings of the National Academy of Sciences of the United States of America. 95: 10814-9. PMID 9724787 DOI: 10.1073/Pnas.95.18.10814 |
0.405 |
|
| 1998 |
Schnell MJ, Buonocore L, Boritz E, Ghosh HP, Chernish R, Rose JK. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. The Embo Journal. 17: 1289-96. PMID 9482726 DOI: 10.1093/Emboj/17.5.1289 |
0.387 |
|
| 1997 |
Schnell MJ, Johnson JE, Buonocore L, Rose JK. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell. 90: 849-57. PMID 9298897 DOI: 10.1016/S0092-8674(00)80350-5 |
0.467 |
|
| 1997 |
Kretzschmar E, Buonocore L, Schnell MJ, Rose JK. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. Journal of Virology. 71: 5982-9. PMID 9223488 DOI: 10.1128/Jvi.71.8.5982-5989.1997 |
0.415 |
|
| 1997 |
Johnson JE, Schnell MJ, Buonocore L, Rose JK. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. Journal of Virology. 71: 5060-8. PMID 9188571 DOI: 10.1128/Jvi.71.7.5060-5068.1997 |
0.494 |
|
| 1996 |
Schnell MJ, Buonocore L, Kretzschmar E, Johnson E, Rose JK. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proceedings of the National Academy of Sciences of the United States of America. 93: 11359-65. PMID 8876140 DOI: 10.1073/Pnas.93.21.11359 |
0.431 |
|
| 1996 |
Mebatsion T, Schnell MJ, Cox JH, Finke S, Conzelmann KK. Highly stable expression of a foreign gene from rabies virus vectors. Proceedings of the National Academy of Sciences of the United States of America. 93: 7310-4. PMID 8692989 DOI: 10.1073/Pnas.93.14.7310 |
0.433 |
|
| 1996 |
Schnell MJ, Buonocore L, Whitt MA, Rose JK. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. Journal of Virology. 70: 2318-23. PMID 8642658 DOI: 10.1128/Jvi.70.4.2318-2323.1996 |
0.407 |
|
| 1996 |
Kretzschmar E, Peluso R, Schnell MJ, Whitt MA, Rose JK. Normal replication of vesicular stomatitis virus without C proteins. Virology. 216: 309-16. PMID 8607260 DOI: 10.1006/Viro.1996.0066 |
0.405 |
|
| 1996 |
Schnell MJ, Conzelmann KK. Polymerase activity of in vitro mutated rabies virus L protein. Virology. 214: 522-30. PMID 8553554 DOI: 10.1006/Viro.1995.0063 |
0.335 |
|
| 1995 |
Mebatsion T, Schnell MJ, Conzelmann KK. Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. Journal of Virology. 69: 1444-51. PMID 7853476 DOI: 10.1128/Jvi.69.3.1444-1451.1995 |
0.438 |
|
| 1994 |
Schnell M, Mebatsion T, Conzelmann K. Infectious rabies viruses from cloned cDNA. The Embo Journal. 13: 4195-4203. DOI: 10.1002/J.1460-2075.1994.Tb06739.X |
0.474 |
|
| Show low-probability matches. |